NAV-201

N/A

Report date: 2024/06/27 11:04:01

NME

Base Information

Drug NameNAV-201

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor III-A modulatorsNatural killer cells stimulants

TargetsLow affinity immunoglobulin gamma Fc region receptor III-A

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNavrogen Inc

China Registration ClassN/A

Active CompaniesNavrogen Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A